179 related articles for article (PubMed ID: 38453992)
1. Pan-cancer analysis reveals PDK family as potential indicators related to prognosis and immune infiltration.
Tao S; Tao K; Cai X
Sci Rep; 2024 Mar; 14(1):5665. PubMed ID: 38453992
[TBL] [Abstract][Full Text] [Related]
2. Targeting pyruvate dehydrogenase kinase signaling in the development of effective cancer therapy.
Anwar S; Shamsi A; Mohammad T; Islam A; Hassan MI
Biochim Biophys Acta Rev Cancer; 2021 Aug; 1876(1):188568. PubMed ID: 34023419
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic Targeting of the Pyruvate Dehydrogenase Complex/Pyruvate Dehydrogenase Kinase (PDC/PDK) Axis in Cancer.
Stacpoole PW
J Natl Cancer Inst; 2017 Nov; 109(11):. PubMed ID: 29059435
[TBL] [Abstract][Full Text] [Related]
4. Metabolic Flexibility in Cancer: Targeting the Pyruvate Dehydrogenase Kinase:Pyruvate Dehydrogenase Axis.
Woolbright BL; Rajendran G; Harris RA; Taylor JA
Mol Cancer Ther; 2019 Oct; 18(10):1673-1681. PubMed ID: 31511353
[TBL] [Abstract][Full Text] [Related]
5. Nematode pyruvate dehydrogenase kinases: role of the C-terminus in binding to the dihydrolipoyl transacetylase core of the pyruvate dehydrogenase complex.
Chen W; Komuniecki PR; Komuniecki R
Biochem J; 1999 Apr; 339 ( Pt 1)(Pt 1):103-9. PubMed ID: 10085233
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of Pyruvate Dehydrogenase Kinase as a Therapeutic Strategy against Cancer.
Sradhanjali S; Reddy MM
Curr Top Med Chem; 2018; 18(6):444-453. PubMed ID: 29788890
[TBL] [Abstract][Full Text] [Related]
7. Metabolic Connection of Inflammatory Pain: Pivotal Role of a Pyruvate Dehydrogenase Kinase-Pyruvate Dehydrogenase-Lactic Acid Axis.
Jha MK; Song GJ; Lee MG; Jeoung NH; Go Y; Harris RA; Park DH; Kook H; Lee IK; Suk K
J Neurosci; 2015 Oct; 35(42):14353-69. PubMed ID: 26490872
[TBL] [Abstract][Full Text] [Related]
8. Site specificity of four pyruvate dehydrogenase kinase isoenzymes toward the three phosphorylation sites of human pyruvate dehydrogenase.
Korotchkina LG; Patel MS
J Biol Chem; 2001 Oct; 276(40):37223-9. PubMed ID: 11486000
[TBL] [Abstract][Full Text] [Related]
9. Targeting the pyruvate dehydrogenase complex/pyruvate dehydrogenase kinase (PDC/PDK) axis to discover potent PDK inhibitors through structure-based virtual screening and pharmacological evaluation.
Gan L; Yang Y; Liang Z; Zhang M; He Y; Zhang SL
Eur J Med Chem; 2024 Jan; 264():116008. PubMed ID: 38056298
[TBL] [Abstract][Full Text] [Related]
10. Differential inhibition of PDKs by phenylbutyrate and enhancement of pyruvate dehydrogenase complex activity by combination with dichloroacetate.
Ferriero R; Iannuzzi C; Manco G; Brunetti-Pierri N
J Inherit Metab Dis; 2015 Sep; 38(5):895-904. PubMed ID: 25601413
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of glycolysis enhances the efficacy of immunotherapy via PDK-mediated upregulation of PD-L1.
Zhang R; Mao G; Tang Y; Li C; Gao Y; Nie W; Song T; Liu S; Zhang P; Tao K; Li W
Cancer Immunol Immunother; 2024 Jun; 73(8):151. PubMed ID: 38832951
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of PDK2 and PDK3 reflects poor prognosis in acute myeloid leukemia.
Cui L; Cheng Z; Liu Y; Dai Y; Pang Y; Jiao Y; Ke X; Cui W; Zhang Q; Shi J; Fu L
Cancer Gene Ther; 2020 Feb; 27(1-2):15-21. PubMed ID: 30578412
[TBL] [Abstract][Full Text] [Related]
13. Pyruvate dehydrogenase kinases (PDKs): an overview toward clinical applications.
Wang X; Shen X; Yan Y; Li H
Biosci Rep; 2021 Apr; 41(4):. PubMed ID: 33739396
[TBL] [Abstract][Full Text] [Related]
14. Tissue-specific kinase expression and activity regulate flux through the pyruvate dehydrogenase complex.
Klyuyeva A; Tuganova A; Kedishvili N; Popov KM
J Biol Chem; 2019 Jan; 294(3):838-851. PubMed ID: 30482839
[TBL] [Abstract][Full Text] [Related]
15. BCKDK regulates the TCA cycle through PDC in the absence of PDK family during embryonic development.
Heinemann-Yerushalmi L; Bentovim L; Felsenthal N; Vinestock RC; Michaeli N; Krief S; Silberman A; Cohen M; Ben-Dor S; Brenner O; Haffner-Krausz R; Itkin M; Malitsky S; Erez A; Zelzer E
Dev Cell; 2021 Apr; 56(8):1182-1194.e6. PubMed ID: 33773101
[TBL] [Abstract][Full Text] [Related]
16. R-lipoic acid inhibits mammalian pyruvate dehydrogenase kinase.
Korotchkina LG; Sidhu S; Patel MS
Free Radic Res; 2004 Oct; 38(10):1083-92. PubMed ID: 15512796
[TBL] [Abstract][Full Text] [Related]
17. Expression parameters of the metabolic pathway genes pyruvate dehydrogenase kinase-1 (PDK-1) and DJ-1/PARK7 in renal cell carcinoma (RCC).
Baumunk D; Reichelt U; Hildebrandt J; Krause H; Ebbing J; Cash H; Miller K; Schostak M; Weikert S
World J Urol; 2013 Oct; 31(5):1191-6. PubMed ID: 22544372
[TBL] [Abstract][Full Text] [Related]
18. Expression of pyruvate dehydrogenase kinase-1 in gastric cancer as a potential therapeutic target.
Hur H; Xuan Y; Kim YB; Lee G; Shim W; Yun J; Ham IH; Han SU
Int J Oncol; 2013 Jan; 42(1):44-54. PubMed ID: 23135628
[TBL] [Abstract][Full Text] [Related]
19. Global view of cognate kinase activation by the human pyruvate dehydrogenase complex.
Guevara EL; Yang L; Birkaya B; Zhou J; Nemeria NS; Patel MS; Jordan F
Sci Rep; 2017 Feb; 7():42760. PubMed ID: 28230160
[TBL] [Abstract][Full Text] [Related]
20. Control of cardiac pyruvate dehydrogenase activity in peroxisome proliferator-activated receptor-alpha transgenic mice.
Hopkins TA; Sugden MC; Holness MJ; Kozak R; Dyck JR; Lopaschuk GD
Am J Physiol Heart Circ Physiol; 2003 Jul; 285(1):H270-6. PubMed ID: 12663261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
